Skip to main content

Lung Diseases clinical trials at UCSF

1 research study open to eligible people

Showing trials for
  • American Lung Association (ALA) Lung Health Cohort

    open to eligible people ages 25-35

    The ALA-LHC is a longitudinal, multi-center cohort study that will enroll approximately 4,000 young adults between the ages of 25-35 who do not have severe lung disease. The overarching objective of the ALA-LHC is to establish a national cohort of young adults for the purpose of defining lung health and developing targets to intercept chronic lung disease at its earliest stages.

    San Francisco, California and other locations

Our lead scientists for Lung Diseases research studies include .

Last updated: